Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Complement as Prognostic Biomarker and Potential Therapeutic Target in Renal Cell Carcinoma
Britney Reese, Ashok Silwal, Elizabeth A. Daugherity, et al.
The Journal of Immunology (2020) Vol. 205, Iss. 11, pp. 3218-3229
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

C1q+ macrophages: passengers or drivers of cancer progression
Margot Revel, Catherine Sautès‐Fridman, Wolf H. Fridman, et al.
Trends in cancer (2022) Vol. 8, Iss. 7, pp. 517-526
Open Access | Times Cited: 103
Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma
Francesco Lasorsa, Monica Rutigliano, Martina Milella, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16515-16515
Open Access | Times Cited: 50
Beyond the Norm: The emerging interplay of complement system and extracellular matrix in the tumor microenvironment
Andrea Balduit, Chiara Agostinis, Roberta Bulla
Seminars in Immunology (2025) Vol. 77, pp. 101929-101929
Closed Access | Times Cited: 5
Complement C3 of tumor-derived extracellular vesicles promotes metastasis of RCC via recruitment of immunosuppressive myeloid cells
Yibi Zhang, Xiaodong Wang, Yinmin Gu, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 4
Open Access | Times Cited: 2
Complement C1s and C4d as Prognostic Biomarkers in Renal Cancer: Emergence of Noncanonical Functions of C1s
Marie V. Daugan, Margot Revel, Jules Russick, et al.
Cancer Immunology Research (2021) Vol. 9, Iss. 8, pp. 891-908
Open Access | Times Cited: 63
Intracellular Factor H Drives Tumor Progression Independently of the Complement Cascade
Marie V. Daugan, Margot Revel, Romane Thouenon, et al.
Cancer Immunology Research (2021) Vol. 9, Iss. 8, pp. 909-925
Open Access | Times Cited: 61
Humoral complementomics – exploration of noninvasive complement biomarkers as predictors of renal cancer progression
Margot Revel, Mikel Rezola Artero, Houcine Hamidi, et al.
OncoImmunology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Nanoparticle-Induced Complement Activation: Implications for Cancer Nanomedicine
Ninh M. La‐Beck, Md. Rakibul Islam, Maciej M. Markiewski
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 54
Clinical Experience and Recent Advances in the Development of Listeria-Based Tumor Immunotherapies
Mariam Oladejo, Yvonne Paterson, Laurence M. Wood
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 54
Inside-Out of Complement in Cancer
Martin Kolev, Madhumita Das, Monica Gerber, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
Hypoxia-induced complement component 3 promotes aggressive tumor growth in the glioblastoma microenvironment
Rebecca Rosberg, Karolina I. Smoląg, Jonas Sjölund, et al.
JCI Insight (2024) Vol. 9, Iss. 19
Open Access | Times Cited: 5
The complement system in clinical oncology: Applications, limitations and challenges
Daniel Ajona, Mark S. Cragg, Rubén Pı́o
Seminars in Immunology (2024) Vol. 77, pp. 101921-101921
Open Access | Times Cited: 4
Plasma proteome fingerprint in kidney diseases
Kirill S. Nikolsky, Arthur T. Kopylov, Valeriya I. Nakhod, et al.
Frontiers in Molecular Biosciences (2025) Vol. 11
Open Access
Complement and the hallmarks of cancer
Mikel Rezola Artero, Andrea Minery, Leon Nedelcev, et al.
Seminars in Immunology (2025) Vol. 78, pp. 101950-101950
Open Access
Host and bacterial urine proteomics might predict treatment outcomes for immunotherapy in advanced non-small cell lung cancer patients
Dávid Dóra, Péter Revisnyei, Alija Pašíć, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Targeting the complement system: notes on therapeutic strategies for renal cancer
Francesco Lasorsa, Monica Rutigliano, Martina Milella, et al.
Future Medicinal Chemistry (2025), pp. 1-3
Closed Access
The complement system and kidney cancer: pathogenesis to clinical applications
Ravikumar Aalinkeel, Richard J. Quigg, Jessy J. Alexander
Journal of Clinical Investigation (2025) Vol. 135, Iss. 9
Open Access
The Role of Complement in Angiogenesis
Maciej M. Markiewski, Elizabeth A. Daugherity, Britney Reese, et al.
Antibodies (2020) Vol. 9, Iss. 4, pp. 67-67
Open Access | Times Cited: 29
Role of Complement in Regulating Inflammation Processes in Renal and Prostate Cancers
Giuseppe Stefano Netti, Rossana Franzin, Alessandra Stasi, et al.
Cells (2021) Vol. 10, Iss. 9, pp. 2426-2426
Open Access | Times Cited: 23
CD8+ T Cell-Based Molecular Classification With Heterogeneous Immunogenomic Landscapes and Clinical Significance of Clear Cell Renal Cell Carcinoma
Xiangkun Wu, Dongmei Jiang, Hongling Liu, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 16
Analysis of SIGLEC12 expression, immunomodulation and prognostic value in renal cancer using multiomic databases
Amobichukwu K. Ogbodo, Denis Mustafov, Mohit Arora, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24286-e24286
Open Access | Times Cited: 2
The Role of the Complement in Clear Cell Renal Carcinoma (ccRCC)—What Future Prospects Are There for Its Use in Clinical Practice?
Martina Panebianco, Chiara Ciccarese, Alessandro Strusi, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 490-490
Open Access | Times Cited: 2
Adjuvant immunotherapy in renal cell carcinoma: a systematic review and meta‐analysis
Carlos Riveros, Emily Huang, Sanjana Ranganathan, et al.
BJU International (2023) Vol. 131, Iss. 5, pp. 553-561
Closed Access | Times Cited: 6
Identification and Validation of Cytotoxicity‐Related Features to Predict Prognostic and Immunotherapy Response in Patients with Clear Cell Renal Cell Carcinoma
Junxiao Yu, Bowen Zhao, You Yu
Genetics Research (2024) Vol. 2024, Iss. 1
Open Access | Times Cited: 1
The Complement System in Ovarian Cancer: An Underexplored Old Path
Yaiza Senent, Daniel Ajona, Antonio González-Martı́n, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3806-3806
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top